Published in Int J Cancer on February 15, 1981
Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med (2012) 12.98
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG. Proc Natl Acad Sci U S A (2013) 2.69
Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol Rev (1988) 2.50
Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial. PLoS One (2013) 1.94
Fc-fusion proteins: new developments and future perspectives. EMBO Mol Med (2012) 1.44
Immunity in human schistosomiasis mansoni. Regulation of protective immune mechanisms by IgM blocking antibodies. J Exp Med (1986) 1.07
Novel HIV vaccine strategies: overview and perspective. Ther Adv Vaccines (2013) 0.90
HIV antibodies for treatment of HIV infection. Immunol Rev (2017) 0.80
Colostrum of healthy mothers contains broad spectrum of secretory IgA autoantibodies. J Clin Immunol (2012) 0.78
Complex immune correlates of protection in HIV-1 vaccine efficacy trials. Immunol Rev (2017) 0.76
New prospects for a preventive HIV-1 vaccine. J Virus Erad (2015) 0.75
Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens. J Clin Microbiol (1985) 7.22
Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen. J Clin Microbiol (1984) 6.75
Monoclonal antibody for rapid laboratory detection of cytomegalovirus infections: characterization and diagnostic application. Mayo Clin Proc (1985) 3.58
Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies. J Virol (1983) 3.06
Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology (1987) 2.53
Naturally occurring scrapie-like spongiform encephalopathy in five domestic cats. Vet Rec (1991) 1.93
Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells. Int J Cancer (1979) 1.89
A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues. Lancet (1997) 1.79
Small intestinal malabsorption in the horse: an assessment of the specificity of the oral glucose tolerance test. Equine Vet J (1991) 1.55
Experimental Salmonella enteritidis infection in chicks. Vet Rec (1989) 1.50
Partial purification of the Epstein-Barr virus nuclear antigen(s). J Biol Chem (1983) 1.44
Early glottic carcinoma treated with open laryngeal procedures. Arch Otolaryngol Head Neck Surg (1994) 1.44
Natural Borna disease virus infection in cats in the United Kingdom. Vet Rec (1998) 1.43
Adenocarcinoma of the larynx. Ann Otol Rhinol Laryngol (1974) 1.42
Production of monoclonal antibody to a late intracellular Epstein-Barr virus-induced antigen. Virology (1984) 1.40
Identification of Epstein-Barr virus strain differences with monoclonal antibody to a membrane glycoprotein. Proc Natl Acad Sci U S A (1982) 1.39
Persistent herpes simplex virus infections established in two Burkitt lymphoma derived cell lines. J Gen Virol (1976) 1.38
Liver lobe torsion in three adult rabbits. J Small Anim Pract (2009) 1.38
Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigens. J Natl Cancer Inst (1976) 1.36
Identification and characterization of a cellular protein that cross-reacts with the Epstein-Barr virus nuclear antigen. J Virol (1984) 1.34
Attaching-effacing bacteria in animals. J Comp Pathol (2005) 1.33
A sensitive enzyme-linked immunosorbent assay (ELISA) against the major EBV-associated antigens. I. Correlation between ELISA and immunofluorescence titers using purified antigens. J Immunol Methods (1984) 1.32
Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis. J Clin Invest (1981) 1.32
Reovirus-like agent (rotavirus) from lambs. Infect Immun (1976) 1.30
Immunological evidence that the nonhormone binding component of avian steroid receptors exists in a wide range of tissues and species. Biochemistry (1985) 1.29
Angiofibroma: treatment trends in 150 patients during 40 years. Laryngoscope (1986) 1.29
Production of antigens associated with Epstein-Barr virus in experimentally infected lymphoblastoid cell lines. J Natl Cancer Inst (1971) 1.28
Evidence for two classes of chromatin-associated Epstein-Barr virus-determined nuclear antigen. J Virol (1982) 1.25
Juvenile angiofibroma. Review of 120 cases. Am J Surg (1973) 1.21
Combined chemoimmunostimulation therapy against murine leukemia. Cancer Res (1972) 1.18
Short-chain organic acids at ph 5.0 kill Escherichia coli and Salmonella spp. without causing membrane perturbation. J Appl Bacteriol (1991) 1.17
Stress-related activation of Epstein-Barr virus. Brain Behav Immun (1991) 1.14
Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol (2000) 1.13
In vitro and in vivo investigations on antibody-dependent cellular cytotoxicity. Curr Top Microbiol Immunol (1978) 1.13
Pathological changes in the small intestine of neonatal calves with enteric colibacillosis. Vet Pathol (1978) 1.13
Comparison of tumor immunity after complete excision, cryonecrosis, and in the presence of persistent tumor. Surg Forum (1970) 1.12
Gasterophilus nasalis infection: prevalence and pathological changes in equids in south-west England. Vet Rec (2000) 1.11
Purification and biologic characterization of a major Epstein Barr virus-induced membrane glycoprotein. J Immunol (1982) 1.10
Allergic fungal sinusitis: the Mayo Clinic experience. Laryngoscope (1994) 1.10
Characterization of a major protein with a molecular weight of 160,000 associated with the viral capsid of Epstein-Barr virus. J Virol (1985) 1.10
Cryosurgery of bronchopulmonary structures. An approach to lesions inaccessible to the rigid bronchoscope. Chest (1977) 1.09
Avian oncornavirus group-specific antigen: detection and quantification by radioimmunoassay. J Virol (1973) 1.09
Identification of an Epstein-Barr virus glycoprotein which is antigenically homologous to the varicella-zoster virus glycoprotein II and the herpes simplex virus glycoprotein B. Virology (1987) 1.08
Symposium. ENT for nonspecialists. External otitis. Postgrad Med (1975) 1.08
Isolation of a T-lymphotropic lentivirus from a persistently leucopenic domestic cat. Vet Rec (1988) 1.08
Thermal considerations in murine tumor killing using hematoporphyrin derivative phototherapy. Cancer Res (1983) 1.08
Requisites for successful cryogenic surgery of cancer. Arch Surg (1971) 1.07
Application of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinoma. Cancer (1983) 1.06
Stress and the memory T-cell response to the Epstein-Barr virus in healthy medical students. Health Psychol (1993) 1.05
Studies on the immunity of the calf to colibacillosis--VII: the experimental reproduction of enteric colibacillosis in colostrum-fed calves. Vet Rec (1977) 1.05
Antibody patterns to Herpesvirus saimiri-induced antigens in owl monkeys. J Natl Cancer Inst (1973) 1.05
Choanal atresia: treatment trends in 47 patients over 33 years. Ann Otol Rhinol Laryngol (1989) 1.05
Protective effect of immune sera against transplantable Moloney virus-induced sarcoma and lymphoma. Cancer Res (1973) 1.03
Bronchoscopic cryotherapy. Ann Otol Rhinol Laryngol (1981) 1.02
Sarcomas of the larynx. Arch Otolaryngol (1980) 1.00
Cytotoxic potential of different lymphoid cell populations against chromium-51 labelled tumour cells. Clin Exp Immunol (1969) 1.00
Natural and experimental infection of normal cattle with Escherichia coli O157. Vet Rec (2000) 0.99
Isolation of steroid receptor binding protein from chicken oviduct and production of monoclonal antibodies. Biochemistry (1985) 0.99
Protein kinase activity associated with a cell cycle regulated, membrane-bound Epstein-Barr virus induced early antigen. Intervirology (1990) 0.98
Occurrence of 'attaching and effacing' lesions in the small intestine of calves experimentally infected with bovine isolates of verocytotoxic E coli. Vet Rec (1989) 0.97
Antibody-dependent cellular cytotoxicity against Epstein-Barr virus-associated antigens in African patients with nasopharyngeal carcinoma. Int J Cancer (1978) 0.97
Pathological changes in the small intestine of neonatal pigs infected with a pig reovirus-like agent (rotavirus). J Comp Pathol (1977) 0.97
Fibrous histiocytoma of the paranasal sinuses. Report of a case. Arch Otolaryngol (1973) 0.96
Scanning and transmission electron microscopic observations on the host-parasite relationship in intestinal cryptosporidiosis of neonatal calves. Res Vet Sci (1983) 0.96
Inconsistent detection of PrP in extraneural tissues of cats with feline spongiform encephalopathy. Vet Rec (2001) 0.95
Cryotherapy for bronchogenic carcinoma: report of a case. Mayo Clin Proc (1975) 0.95
Solitary extramedullary plasmacytoma of the larynx. Arch Otolaryngol (1977) 0.95
Cryosurgical control of cancer: effects of freeze rates, tumor temperatures, and ischemia. Ann Otol Rhinol Laryngol (1973) 0.93
Autografts of uncrushed and crushed bone and cartilage. Experimental observations and clinical implications. Arch Otolaryngol (1979) 0.93
Juvenile angiofibromas. Behavior and treatment of extensive and residual tumors. Arch Otolaryngol Head Neck Surg (1986) 0.93
Pathological changes in the small intestine of neonatal calves naturally infected with reo-like virus (rotavirus). Vet Rec (1978) 0.93
Papain solubilization of the Epstein-Barr virus-induced membrane antigen. J Virol (1978) 0.93
Demonstration of Cryptosporidia in the small intestine of a calf by light, transmission electron and scanning electron microscopy. Vet Rec (1978) 0.92
Antibodies to Epstein-Barr virus in patients with nasopharyngeal carcinoma and in comparison groups. Ann Otol Rhinol Laryngol (1984) 0.92
Scanning electron microscopic observations of segmented filamentous bacteria in the small intestine of domestic fowl. Vet Rec (1982) 0.91
Human Herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report. Mult Scler (1998) 0.91
Pathological changes associated with group EF-4 bacteria in the lungs of a dog and a cat. Vet Rec (1982) 0.91
Resident work hours and working environment in otolaryngology. Analysis of daily activity and resident perception. JAMA (1991) 0.91
Sero-epidemiological investigations on human herpesvirus 6 (HHV-6) infections using a newly developed early antigen assay. Int J Cancer (1991) 0.91
Nasal manifestations of allergic granulomatosis and angiitis (Churg-Strauss syndrome). Otolaryngol Head Neck Surg (1979) (1980) 0.90
Epstein-Barr virus-specific antibody-dependent cellular cytotoxicity in patients with Burkitt's lymphoma. Int J Cancer (1979) 0.90
The humoral and cell mediated immune response of young chicks to Salmonella typhimurium and S. Kedougou. Br Vet J (1993) 0.90
Neoplasia involving the middle ear cavity of dogs. Vet Rec (1989) 0.90
Epitope mapping of the major Epstein-Barr virus outer envelope glycoprotein gp350/220. J Gen Virol (1987) 0.90
Infection of gnotobiotic calves with Escherichia coli o157:h7 strain A84. Vet Rec (1999) 0.89
Transmission of feline spongiform encephalopathy to mice. Vet Rec (1994) 0.89
Immunotherapeutic effect of tumor necrosis after cryosurgery, electrocoagulation, and ligation. J Surg Oncol (1979) 0.89
Augmentation of lymphocyte cytotoxicity by antibody to herpesvirus saimiri associated antigens. Proc Natl Acad Sci U S A (1975) 0.89
HLA and nasopharyngeal carcinoma in North American Caucasoids. Tissue Antigens (1983) 0.89
Aerosol infection of calves and mice with Salmonella typhimurium. Vet Rec (1988) 0.88